Hemorrhagic shock and encephalopathy syndrome--the markers for an early HSES diagnosis.
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers / Q000032:analysis*; D001927:Brain Diseases / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D001929:Brain Edema / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D005440:Fluid Therapy / Q000379:methods; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007022:Hypotension / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D007223:Infant; D008297:Male; D010976:Platelet Count; D011237:Predictive Value of Tests; D011379:Prognosis; D012151:Resuscitation / Q000379:methods; D012771:Shock, Hemorrhagic / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D013577:Syndrome; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D015415:Biomarkers; D006454:Hemoglobins; D014662:Vasoconstrictor Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase